Sort   by:  
 Page size 
UnknownRandomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
Not available
S-EPMC3970172 | biostudies-literature
UnknownRandomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.
Not available
S-EPMC3383121 | biostudies-literature
UnknownCirculating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.
Not available
S-EPMC3970171 | biostudies-literature
UnknownThe Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.
Not available
S-EPMC4546911 | biostudies-literature
UnknownPredicting attitudinal and behavioral responses to COVID-19 pandemic using machine learning.
Not available
S-EPMC9381137 | biostudies-literature
UnknownEffects of combination lipid therapy in type 2 diabetes mellitus.
Not available
S-EPMC2879499 | biostudies-literature
UnknownEffects of intensive blood-pressure control in type 2 diabetes mellitus.
Not available
S-EPMC4123215 | biostudies-literature
UnknownLong-term effects of intensive glucose lowering on cardiovascular outcomes.
Not available
S-EPMC4083508 | biostudies-literature
UnknownEffect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Not available
S-EPMC4123233 | biostudies-literature
UnknownEffects of intensive glucose lowering in type 2 diabetes.
Not available
S-EPMC4551392 | biostudies-literature
Sort   by:  
 Page size